The gene expression of Tyrosine kinase 2 (TYK2), interferon regulatory factor 5 (IRF5), and CTLA4 are associated with SLE and conferred risk for DLE and SCLE (159). The gene discussed is TYK2; the disease is systemic lupus erythematosus.